Literature DB >> 19503982

Quality of life and site of the lesion in dermatological patients.

Martha Wallig Brusius Ludwig1, Margareth da Silva Oliveira, Marisa Campio Muller, João Feliz Duarte de Moraes.   

Abstract

BACKGROUND: The visible aspect of skin lesions and its psychological impact interfere in the quality of life of patients.
OBJECTIVES: To assess the quality of life and site of dermatological lesion; to check associations between variables and compare levels of quality of life in patients with lesions on the face and/or hands and patients with lesions in parts of the body other than face and/or hands.
METHODS: descriptive, association-based cross-sectional study. Two hundred and five subjects were assessed using SF-36 Generic Life Quality Questionnaire "The Medical Outcomes Study 36-item Short-Form Health Survey" (SF-36); the Dermatology Life Quality Index DLQI-BRA, and socio-demographical and lesion site data files.
RESULTS: No significant differences were observed in the results for quality of life between the two groups but the number of associations between SF-36 and DLQI-BRA was higher in the group with lesions on the face and/or hands. Significant differences were verified in a further detailed division into five groups. The significant difference (p=0.05) appeared between the group with lesions on the face and/or hands and the group with generalized lesions, being that the latter presented an average ranking of 114.06 compared with 69.1935 in the former group.
CONCLUSION: Regardless of the site of lesion, the feeling of exposure and the damages to which the dermatological patients are exposed are similar. It seems that skin diseases bring about the feeling of exposure and embarrassment no matter which site of the body is affected because in any intimate approach there is some sort of exposure involved.

Entities:  

Mesh:

Year:  2009        PMID: 19503982     DOI: 10.1590/s0365-05962009000200007

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  8 in total

1.  Comparing the impact of psoriasis and atopic dermatitis on quality of life: co-calibration of the PSORIQoL and QoLIAD.

Authors:  J Twiss; S P McKenna
Journal:  Qual Life Res       Date:  2014-01-30       Impact factor: 4.147

2.  Quality of life index in autoimmune bullous dermatosis patients.

Authors:  Mariana Álvares Penha; Joyce Godoy Farat; Hélio Amante Miot; Sílvia Regina Catharino Sartori Barraviera
Journal:  An Bras Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.896

3.  Translation, cross-cultural adaptation and validation of the vitiligo-specific health-related quality of life instrument (VitiQoL) into Brazilian Portuguese.

Authors:  Juliana Catucci Boza; Roopal V Kundu; Amanda Fabbrin; Roberta Horn; Natalia Giongo; Tania Ferreira Cestari
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

4.  Cost-utility of first-line actinic keratosis treatments in Finland.

Authors:  Erkki J Soini; Taru Hallinen; Anna-Leena Sokka; Kari Saarinen
Journal:  Adv Ther       Date:  2015-05-26       Impact factor: 3.845

5.  Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis.

Authors:  Pratik Gahalaut; Nitin Mishra; Puneet S Soodan; Madhur K Rastogi
Journal:  Dermatol Res Pract       Date:  2014-09-04

6.  Evaluating of life quality in patients with acne vulgaris using generic and specific questionnaires.

Authors:  Reza Ghaderi; Alireza Saadatjoo; Faezeh Ghaderi
Journal:  Dermatol Res Pract       Date:  2013-11-25

7.  Quality of life profile and correlated factors in chronic leg ulcer patients in the mid-west of São Paulo State, Brazil.

Authors:  Patrick Alexander Wachholz; Paula Yoshiko Masuda; Dejair Caitano Nascimento; Cecilia Midori Higashi Taira; Norma Gondim Cleto
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

8.  Evaluation of anxiety and depression prevalence in patients with primary severe hyperhidrosis.

Authors:  Gleide Maria Gatto Bragança; Sonia Oliveira Lima; Aloisio Ferreira Pinto Neto; Lucas Menezes Marques; Enaldo Vieira de Melo; Francisco Prado Reis
Journal:  An Bras Dermatol       Date:  2014 Mar-Apr       Impact factor: 1.896

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.